ESC 365 - FOURIER - Efficacy of PCSK9 inhibition with evolocumab in patients with Metabolic Syndrome

ESC Premium Access

FOURIER - Efficacy of PCSK9 inhibition with evolocumab in patients with Metabolic Syndrome

Session: Late Breaking Pharmacological Science

Topic: Drug therapy

Speaker: Professor P. Deedwania (Fresno, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Prakash Deedwania

University of California San Francisco, Fresno (United States of America)

1 presentation

0 follower

12 more presentations in this session

Panel discussants.

CLARIFY - First-line anti-ischemic agents use and long-term clinical outcomes in stable coronary artery disease

Speaker: Doctor E. Sorbets (Paris, FR)

Panel discussion.

Panel discussion.

SAIT - Specific Active immunotherapy (SAIT) against PCSK9 is safe and lowers circulating LDL-C in humans

Speaker: Associate Professor M. Bauer (Vienna, AT)

Access the full session

Late Breaking Pharmacological Science

Speakers: Professor P. Deedwania, Doctor E. Sorbets, Associate Professor M. Bauer

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources